Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
about
Pharmacotherapy for stimulant-related disordersChronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literatureSustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial.Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.Psychostimulant addiction treatment.Effects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys.Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysisMethamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeysFactors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders.The effects of methylphenidate on cognitive control in active methamphetamine dependence using functional magnetic resonance imaging.Novel interventions to prevent HIV and HCV among persons who inject drugs.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Retention predictors of a smoking treatment provided by a public psychosocial unit in Brazil.Addictive potential of novel treatments for refractory depression and anxiety.
P2860
Q26829186-13611D7B-FAF6-4A04-ADC0-407441DFB840Q30873118-D8D2C55B-2BB0-4F90-94F1-E839502EB151Q34021980-CB743FED-E8C9-4E95-B0D1-5EC2987B6866Q34181746-C14026B5-6B7E-4D3F-8600-D7F73F84CDCFQ34981228-0283DF01-3664-4F9C-8686-C9A45A238436Q35576598-C23BD884-A0B8-45D7-A68B-D9F53B283529Q35915231-0ED5F951-A81D-4D54-AA69-1B7E1E00ECA8Q36090475-744E001C-4CDD-43BF-9962-3A4DCBD85DCCQ36192104-EC790193-8895-47EF-98B5-2831A28C4528Q36655731-7A57530A-93F1-4687-81CF-5BBB48BF55D5Q36813731-0205FA1E-38B7-4B5A-B774-83FD7CDAF421Q37620947-359E801C-F330-4B68-93B3-93EBA5C79A2DQ38318678-73AAB7C9-7C69-4355-8FA3-1C2753C137BDQ39034288-0BC1912B-9120-49A3-9C02-6035558BBFFCQ50626987-90B0997C-9D2C-4134-AE77-9CACCCBCE7D5Q55334438-13E57218-5B88-4F55-93A7-286FD984B260
P2860
Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Extended-release methylphenida ...... ind, placebo-controlled trial.
@en
Extended-release methylphenida ...... ind, placebo-controlled trial.
@nl
type
label
Extended-release methylphenida ...... ind, placebo-controlled trial.
@en
Extended-release methylphenida ...... ind, placebo-controlled trial.
@nl
prefLabel
Extended-release methylphenida ...... ind, placebo-controlled trial.
@en
Extended-release methylphenida ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P50
P356
P1433
P1476
Extended-release methylphenida ...... ind, placebo-controlled trial.
@en
P2093
Antti Mikkonen
Carina Walters
Greg Gamble
Helena Vorma
Jaana Föhr
Jussi Kauhanen
Kimmo Kuoppasalmi
Mika Kallio
Outi Kuikanmäki
Pekka Tuomola
P2860
P304
P356
10.1111/ADD.12109
P407
P577
2013-03-01T00:00:00Z